Topic: atrial fibrillation
The regulatory nod covers AliveCor’s KardiaBand, a device that clips onto Apple’s smartwatch and performs EKG readings.
The FDA OK'd Acutus' real-time cardiac mapping system that monitors a patient’s atrial fibrillation during ablation.
The FDA has cleared Abbott’s smartphone-compatible ICM, which facilitates the remote monitoring of patients with arrhythmias.
Boston Scientific forked over $175 million up front for Apama Medical, which is working on a new treatment for afib.
The regulatory nod clears the cardiac disorder specialist to start selling the atrial fibrillation device in the European Union later this year.
It's rare for a devicemaker to air a TV ad, but Boston Sci's Watchman ad is part of its plan to stay relevant in an industry that is consolidating.
Abbott announced the CE mark and launch of its smartphone-compatible insertable cardiac monitor, designed to help physicians spot arrhythmias remotely.
Advanced Cardiac Therapeutics raised $45 million in equity, which will drive global clinical development for its next-generation ablation catheter.
CardioFocus raised $20 million, which will boost the commercialization of its endoscopic ablation system for the treatment of a fib.